Chinese healthcare-focused venture capital and private equity firm HighLight Capital has reached the close of its second US dollar-denominated fund at the hard cap of $250 million, as per a report in AVCJ.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
